Quince Therapeutics
QNCX
$0.92
Share price
-4.17%
Change (1 day)
-43.56%
Change (1 year)
Categories
Quince Therapeutics (QNCX) - P/B ratio
P/B ratio as of May 2024 : 0.4952
According to Quince Therapeutics's latest financial reports the company has a price-to-book ratio of 0.4952.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Quince Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 0.5290 | 131.08% |
| 2022-12-31 | 0.2289 | -92.8% |
| 2021-12-31 | 3.18 | -33.16% |
| 2020-12-31 | 4.76 | -63.56% |
| 2019-12-31 | 13.1 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.82 | 469.32% | 🇺🇸 USA |